TRACK A – COVID IN 2021 & BEYOND
Measuring the Economic & Community Impact of COVID-19

TRACK B – CRO & CMO
Made in Georgia | How Georgia’s Manufacturers Play a Major Role in the Global Supply Chain

TRACK C – BIOPHARMACEUTICALS & DRUGS
Best Practices that Increase “Over-Time” Virtual Patient Engagement

TRACK D – MEDICAL DEVICE & DIGITAL HEALTH
Reimbursement, Regulatory, and Clinical Strategy: Think About it Early & Often

​

Welcome, Sponsor Remarks & PitchRound Awards:
• Maria Thacker-Goethe, MPH, President & CEO, Georgia Bio; CEO, Center for Global Health Innovation
• Holly Snow, Director, State Government Affairs, Amgen
• Sherry Farrugia, Interim CEO, Global Center for Medical Innovation (GCMI)

Keynote Address: “Devices & Data: Impacts on the Healthcare Continuum”
• Ken Berta, Executive Director, Global Health Crisis Coordination Center
• Dan Brady, Business Leader for Connected Care Informatics, Philips
• Steven Lazer, Global Healthcare CTO, Dell EMC Industries; Chief Cloud Officer, Dell EMC
• Patty Obermaier, Vice President, US Health and Life Sciences, Microsoft

​

Global Health Crisis Coordination Center (GHC3) Announcement

Keynote Address: “Becoming Better Ancestors: Lessons from Past Successes in Disease Eradication”
• Dr. Seth Berkley, CEO, Gavi, the Vaccine Alliance; Founder, Founder & past President and CEO of the International AIDS Vaccine Initiative (IAVI)
• Dr. William H. Foege, Emory Presidential Distinguished Professor of Global Health Emeritus; Director, Centers for Disease Control & Prevention, 1977-1983; Director, The Carter Center, 1986-1992; Founder, Task Force for Global Health; Senior Fellow, Bill & Melinda Gates Foundation; Co-Chair, NASEM committee developing Framework for Equitable Allocation of a COVID-19 Vaccine.
• Dr. Helene Gayle, President & CEO, The Chicago Community Trust; Co-Chair, National Academies of Sciences, Engineering, Medicine committee developing Framework for Equitable Allocation of a COVID-19 Vaccine; President & CEO, CARE, 2006-2015; CEO, McKinsey Social Initiative, 2015-2017

​

​

TRACK A – COVID IN 2021 & BEYOND
COVID-19, Life Sciences & the Law: Opportunities & Pitfalls

TRACK B – CRO & CMO
Adapting and Leading in the COVID-19 Reality

TRACK C – BIOPHARMACEUTICALS & DRUGS
Cold Chain: The Lifeline of Global Healthcare & Life Sciences

TRACK D – MEDICAL DEVICE & DIGITAL HEALTH
Georgia MedTech: Thriving Post-COVID-19

​

​

​

​